Literature DB >> 2213078

Hospitalization experience of Navajo subjects with type II diabetes and matched controls: an historical cohort study.

P J O'Connor1, B F Crabtree, R M Nakamura, D Kelley.   

Abstract

Using an historical cohort study design with a 12 year follow-up, we found that 77 Navajo adults with type II diabetes mellitus were hospitalized at a rate of 335 hospitalizations per 1000 patient years compared to a rate of 167 hospitalizations per 1000 patient years for 77 age, sex, and residence matched non-diabetic controls, yielding a risk ratio of 2.0. Using matched pairs analysis (sign test), the observed difference in number of hospital admissions is statistically significant (z = 2.30, p less than 0.05). The average duration of hospitalization, however, was not statistically different in matched pairs analysis (z = 0.95, p greater than 0.05). The 136 excess hospitalizations of the diabetic subjects included 45 admissions for poor metabolic control of diabetes, 50 excess admissions for infectious disease, and 26 excess admissions for conditions of the heart, eye, kidney, or non-traumatic amputation. In multivariate analyses, variables found to be associated with greater hospitalization experience among the 77 diabetic subjects in the 12 years follow-up period included older age at entry to the study, poorer metabolic control early in the study period, and presence of diabetic complications.

Entities:  

Mesh:

Year:  1990        PMID: 2213078     DOI: 10.1016/0895-4356(90)90072-w

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  Multimethod research: approaches for integrating qualitative and quantitative methods.

Authors:  K C Stange; W L Miller; B F Crabtree; P J O'Connor; S J Zyzanski
Journal:  J Gen Intern Med       Date:  1994-05       Impact factor: 5.128

2.  Ethics in public health research: changing patterns of mortality among American Indians.

Authors:  Stephen J Kunitz
Journal:  Am J Public Health       Date:  2008-01-30       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.